Dr. Charles Majka, M.D.
What this data tells you about Dr. Majka
Dr. Charles Majka is a family medicine in Decatur, TX, with 16 years in practice. Based on federal Medicare data, Dr. Majka performed 5,713 Medicare services across 3,707 unique beneficiaries.
Between the years covered by Open Payments, Dr. Majka received a total of $5,287 from 55 pharmaceutical and/or device companies across 323 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Majka is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,280 | $83 | $264 |
| Comprehensive metabolic blood panel | 427 | $10 | $30 |
| Complete blood count (CBC) with differential | 423 | $8 | $19 |
| Lipid panel (cholesterol and triglycerides) | 384 | $13 | $30 |
| Thyroid stimulating hormone (TSH) test | 377 | $16 | $33 |
| Annual wellness visit, follow-up | 265 | $124 | $269 |
| Hemoglobin A1c test (diabetes monitoring) | 261 | $10 | $27 |
| Advance care planning consultation, first 30 min | 241 | $76 | $172 |
| Vitamin D level test | 161 | $29 | $66 |
| Drug injection, under skin or into muscle | 160 | $10 | $69 |
| Urine microalbumin test (kidney screening) | 143 | $6 | $12 |
| Creatinine test (kidney function) | 143 | $5 | $12 |
| Office visit, established patient (20-29 min) | 129 | $56 | $186 |
| Dexamethasone injection (steroid) | 100 | $0 | $6 |
| Free thyroxine (T4) test | 96 | $9 | $20 |
| Thyroid hormone, t3 measurement, free | 96 | $17 | $34 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 94 | $29 | $84 |
| Steroid injection (triamcinolone) | 88 | $1 | $5 |
| Annual depression screening | 55 | $18 | $38 |
| Bone density scan (DEXA) | 50 | $36 | $74 |
| Urinalysis, manual | 48 | $3 | $7 |
| Injection, methylprednisolone acetate, 40 mg | 48 | $6 | $13 |
| Chronic care management, first 20 min/month | 45 | $40 | $83 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 42 | $35 | $90 |
| Magnesium level test | 41 | $7 | $15 |
| PSA test (prostate cancer screening) | 40 | $18 | $41 |
| C-reactive protein test (inflammation marker) | 36 | $5 | $12 |
| Creatine kinase (cardiac enzyme) level, total | 30 | $6 | $13 |
| Detection test by immunoassay technique for influenza virus | 30 | $14 | $28 |
| Detection test by immunoassay with direct visual observation for influenza virus | 28 | $16 | $33 |
| New patient office visit (45-59 min) | 28 | $81 | $340 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 22 | $159 | $342 |
| Basic metabolic blood panel | 21 | $8 | $17 |
| Measurement of total estradiol (hormone) | 21 | $27 | $62 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 19 | $14 | $31 |
| Iron level test | 18 | $6 | $13 |
| Iron binding capacity test | 18 | $9 | $19 |
| Transitional care management services for problem of high complexity | 18 | $212 | $569 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 18 | $38 | $108 |
| New patient office visit (30-44 min) | 17 | $60 | $228 |
| Folic acid level test | 16 | $14 | $33 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 16 | $38 | $84 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 16 | $15 | $34 |
| Parathyroid hormone level test | 15 | $40 | $92 |
| Uric acid level test | 14 | $4 | $10 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 14 | $9 | $30 |
| Sed rate test (inflammation marker) | 13 | $3 | $5 |
| Prostate cancer screening; prostate specific antigen test (psa) | 13 | $19 | $39 |
| Electrocardiogram (EKG), 12-lead | 12 | $11 | $30 |
| Transitional care management services for problem of at least moderate complexity | 12 | $157 | $420 |
| Ferritin level test (iron stores) | 11 | $13 | $30 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Majka is a clinical cardiology specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (low-engagement, top 12%), with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Majka experienced with office visit, established patient (30-39 min)?
Does Dr. Majka receive payments from pharmaceutical companies?
How do Dr. Majka's costs compare to other family medicines in Decatur?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology